Publication | Open Access
Dupilumab significantly improves skin barrier function in patients with moderate‐to‐severe atopic dermatitis
99
Citations
20
References
2022
Year
Inhibition of IL-4/IL-13 signaling by dupilumab allows restoration of skin lipid composition and barrier function in patients with moderate-to-severe AD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1